Prostanoid IP receptor agonist

This page covers all Prostanoid IP receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Prostanoid IP receptor.

Targets

Prostanoid IP receptor

Phase 3 pipeline (1)

• ONO-5920 · Ono Pharmaceutical Co. Ltd · Cardiovascular
  ONO-5920 is a selective prostanoid receptor agonist that activates IP receptors to promote vasodilation and inhibit platelet aggregation.